Which has the lower trailing P/E, ADUS or HRMY?

HRMY has the lower trailing P/E: ADUS trades at 19.85 and HRMY at 12.78. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ADUS or HRMY?

Over the past five years, HRMY grew revenue faster — ADUS at a 12.67% CAGR versus HRMY at 32.47%.

Is ADUS or HRMY more profitable?

HRMY runs the higher net margin — ADUS at 7.13% versus HRMY at 18.88%.

How have ADUS and HRMY total returns compared?

Over the past 5 years, ADUS delivered 8.33% and HRMY delivered 0.91% annualized total return. Past performance doesn't predict future results.

Addus HomeCare Corporation (ADUS) vs Harmony Biosciences Holdings, Inc. (HRMY)

A side-by-side comparison of Addus HomeCare Corporation and Harmony Biosciences Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADUS

Addus HomeCare Corporation

$2.11B

$113.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

HRMY

Harmony Biosciences Holdings, Inc.

$2.28B

$39.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ADUS vs HRMY

growth of $100 · dividends reinvested · last 6y

ADUS +16.8% (+2.6%/yr)HRMY +7.9% (+1.3%/yr)ADUS compounded faster over this window

ADUS HRMY

ADUS vs HRMY: by the numbers

•HRMY is the larger company ($2.28B vs $2.11B market cap).
•HRMY trades at the lower trailing earnings multiple (12.78 vs 19.85 P/E), one valuation lens rather than an overall verdict.
•HRMY converts more revenue to profit (18.88% vs 7.13% net margin).
•HRMY grew revenue faster over the past five years (32.47% vs 12.67% CAGR).

Metrics side by side

Valuation

Metric	ADUS	HRMY
P/E ratio	19.85	12.78
Forward P/E	16.06	9.98
PEG ratio	0.98	N/A
P/S ratio	1.43	2.37
P/B ratio	1.84	2.28
EV / EBITDA	12.86	7.36
FCF yield	7.25%	15.57%

Profitability

Metric	ADUS	HRMY
Gross margin	32.36%	75.42%
Operating margin	10.04%	24.03%
Net margin	7.13%	18.88%
ROE	9.17%	18.14%
ROIC	8.61%	14.96%

Growth (annualized)

Metric	ADUS	HRMY
Revenue CAGR (5Y)	12.67%	32.47%
EPS CAGR (5Y)	19.61%	N/A
FCF CAGR (5Y)	24.41%	48.43%
Total return CAGR (5Y)	8.33%	0.91%

Frequently asked

Which has the lower trailing P/E, ADUS or HRMY?: HRMY has the lower trailing P/E: ADUS trades at 19.85 and HRMY at 12.78. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ADUS or HRMY?: Over the past five years, HRMY grew revenue faster — ADUS at a 12.67% CAGR versus HRMY at 32.47%.
Is ADUS or HRMY more profitable?: HRMY runs the higher net margin — ADUS at 7.13% versus HRMY at 18.88%.
How have ADUS and HRMY total returns compared?: Over the past 5 years, ADUS delivered 8.33% and HRMY delivered 0.91% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADUS analysis Full HRMY analysis Interactive comparison tool

Dig into the metrics

Addus HomeCare P/E ratio Harmony Biosciences P/E ratio Addus HomeCare ROE Harmony Biosciences ROE Addus HomeCare operating margin Harmony Biosciences operating margin Addus HomeCare revenue growth Harmony Biosciences revenue growth Addus HomeCare free cash flow Harmony Biosciences free cash flow

Addus HomeCare & Harmony Biosciences appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.